Jennison Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $113M | Sell |
|
|||||
|
2025
Q1 | $156M | Sell |
|
|||||
|
2024
Q4 | $155M | Sell |
|
|||||
|
2024
Q3 | $342M | Buy |
|
|||||
|
2024
Q2 | $272M | Sell |
|
|||||
|
2024
Q1 | $393M | Buy |
|
|||||
|
2023
Q4 | $299M | Buy |
|
|||||
|
2023
Q3 | $224M | Buy |
|
|||||
|
2023
Q2 | $202M | Sell |
|
|||||
|
2023
Q1 | $245M | Sell |
|
|||||
|
2022
Q4 | $331M | Buy |
|
|||||
|
2022
Q3 | $265M | Buy |
|
|||||
|
2022
Q2 | $218M | Sell |
|
|||||
|
2022
Q1 | $313M | Buy |
|
|||||
|
2021
Q4 | $254M | Buy |
|
|||||
|
2021
Q3 | $201M | Buy |
|
|||||
|
2021
Q2 | $121M | Buy |
|
|||||
|
2021
Q1 | $79.9M | Buy |
|
|||||
|
2020
Q4 | $71.2M | Buy |
|
|||||
|
2020
Q3 | $47.8M | Buy |
|
|||||
|
2020
Q2 | $43.4M | Buy |
|
|||||
|
2020
Q1 | $1.1M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $20.6M | Sell |
|
|||||
|
2018
Q1 | $586M | Sell |
|
|||||
|
2017
Q4 | $1.1B | Buy |
|
|||||
|
2017
Q3 | $544M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $25.5M | Sell |
|
|||||
|
2016
Q3 | $146M | Sell |
|
|||||
|
2016
Q2 | $146M | Sell |
|
|||||
|
2016
Q1 | $135M | Sell |
|
|||||
|
2015
Q4 | $158M | Sell |
|
|||||
|
2015
Q3 | $167M | Buy |
|
|||||
|
2015
Q2 | $162M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $145M | Buy |
|
|||||
|
2014
Q3 | $125M | Buy |
|
|||||
|
2014
Q2 | $105M | Sell |
|
|||||
|
2014
Q1 | $104M | Buy |
|
|||||
|
2013
Q4 | $77M | Buy |
|